Replies to post #751827 on NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

As always, I'd love to hear from you—thank you! On a lighter note, I can't wait for two more months, or at most, one month.😄

As I've mentioned before, for the next 2 months we are well within the precedented "normal" timeframe for approval.

[StonkMaster]

Lazertinib approved for use in combination with amivantamab for the treatment of adults with non-small cell lung cancer

https://www.gov.uk/government/news/lazertinib-approved-for-use-in-combination-with-amivantamab-for-the-treatment-of-adults-with-non-small-cell-lung-cancer?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=38e7cbd1-9503-4735-8318-3d76dbcde455&utm_content=immediately

[sentiment_stocks]

So now (looking at your post from end of Feb 2025) if the CHM Nov 25 meeting about a glioblastoma medicine was about DCVax-L, then it would seem that we are looking at 521 days (17 months) from the first CHM meeting to the second one.

As of today, 2/28/25, we are sitting at 246 since the first CHM meeting.

246 + 275 (9 months - March 2025 to October 3025) = 521 days or a bit more than 17 months.

Note: I’ve edited this from adding 8 months to adding 9 months. Had the 10/30 CHM meeting in my head from the other product under discussion.